Access Granted: A Strategic Guide to Marketing to U.S. and Global Pharmaceutical Payers

Branding Marketing Social Media

The ability to articulate a compelling and evidence-backed value proposition to these economic buyers is now arguably the most critical capability for any biopharma company launching a new product.

A New White Paper by C&A Health

In the modern pharmaceutical landscape, a new reality has taken hold: clinical success is necessary but no longer sufficient for commercial triumph. The journey from a promising molecule to a market-leading therapy is now governed by a powerful set of gatekeepers who have become the most critical audience for pharmaceutical marketers: payers. These entities—ranging from private health insurers and government bodies to influential pharmacy benefit managers (PBMs)—wield immense power, and their decisions on access and reimbursement dictate a product’s ultimate success or failure.

Market access decisions directly influence every facet of a brand’s life, from physician prescribing patterns and patient out-of-pocket costs to product distribution, profitability, and overall customer perception. The traditional go-to-market strategy, once centered on deploying a sales force to detail physicians, is no longer adequate in a market characterized by the increasing power of payers and regulators.